Reporting and Analysis Plan - Evaluation of Secondary Malignancies in Patients Treated with Dabrafenib in Randomized, Controlled Trials (201710) First published 25/08/2014 Last updated 14/03/2024 EU PAS number:EUPAS7317 Study Finalised